Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model

Toxicology and Applied Pharmacology

Volumn 229, Issue 1, 2008, Pages 94-101

  Tafazoli, Shahrzad ^a   Mashregi, Mariam ^b   O'Brien, Peter J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Hepatotoxicity; Hydrazine; Inflammation; Isoniazid; Oxidative stress

Indexed keywords

1 AMINOBENZOTRIAZOLE; 4 NITROPHENYL PHOSPHATE; ACETOHYDRAZIDE; CARBONYL DERIVATIVE; ESTERASE INHIBITOR; HYDRAZINE; HYDROGEN PEROXIDE; ISONIAZID; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; CYTOTOXICITY; HYDROLYSIS; INFLAMMATION; LIVER CELL; LIVER LYSOSOME; LIVER TOXICITY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; ANTITUBERCULAR AGENTS; HEPATOCYTES; HYDRAZINES; HYDROGEN PEROXIDE; INFLAMMATION; ISONIAZID; LIVER DISEASES; LYSOSOMES; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 42749086613     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.01.002     Document Type: Article

References (47)

1. Albano E., and Tomasi A. Spin trapping of free radical intermediates produced during the metabolism of isoniazid and iproniazid in isolated hepatocytes. Biochem. Pharmacol. 36 (1987) 2913-2920
2. Amenta J.S., and Johnston E.H. The effects of hydrazine upon the metabolism of amino acids in the rat liver. Lab. Invest. 12 (1963) 921-928
3. Anari M.R., Khan S., Jatoe S.D., and O'Brien P.J. Cytochrome P450 dependent xenobiotic activation by physiological hydroperoxides in intact hepatocytes. Eur. J. Drug Metab Pharmacokinet. 22 (1997) 305-310
4. Andersson B.S., Aw T.Y., and Jones D.P. Mitochondrial transmembrane potential and pH gradient during anoxia. Am. J. Physiol. 252 (1987) C349-C355
5. Bataller R., Schwabe R.F., Choi Y.H., Yang L., Paik Y.H., Lindquist J., Qian T., Schoonhoven R., Hagedorn C.H., Lemasters J.J., and Brenner D.A. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J. Clin. Invest. 112 (2003) 1383-1394
6. Buch H., Buzello W., Heymann E., and Krisch K. Inhibition of phenacetin- and acetanilide-induced methemoglobinemia in the rat by the carboxylesterase inhibitor bis-[p-nitrophenyl] phosphate. Biochem. Pharmacol. 18 (1969) 801-811
7. Buchweitz J.P., Ganey P.E., Bursian S.J., and Roth R.A. Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?. J. Pharmacol. Exp. Ther. 300 (2002) 460-467
8. Cohen G., and Hochstein P. Generation of hydrogen peroxide in erythrocytes by hemolytic agents. Biochemistry 3 (1964) 895-900
9. De Minicis S., and Brenner D.A. NOX in liver fibrosis. Arch. Biochem. Biophys. 462 (2007) 266-272
10. Dhand R., Gilhotra R., Sehgal S., and Malik S.K. Incidence of isoniazid-induced antinuclear antibodies in patients of tuberculosis. Indian J. Med. Res. 85 (1987) 503-507
11. Diaz-Cruz A., Guinzberg R., Guerra R., Vilchis M., Carrasco D., Garcia-Vazquez F.J., and Pina E. Adrenaline stimulates H2O2 generation in liver via NADPH oxidase. Free Radic. Res. 41 (2007) 663-672
12. Dominguez A.M., Amenta J.S., Hill C.S., and Domanski T.J. Morphologic and biochemical alteration in the kidney of the hydrazine-treated rat. Aeromed. Acta 22 (1962) 1094-1097
13. Garibaldi R.A., Drusin R.E., Ferebee S.H., and Gregg M.B. Isoniazid-associated hepatitis. Report of an outbreak. Am. Rev. Respir. Dis. 106 (1972) 357-365
14. Hartley D.P., Kroll D.J., and Petersen D.R. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts. Chem. Res. Toxicol. 10 (1997) 895-905
15. Hussain S.M., and Frazier J.M. Cellular toxicity of hydrazine in primary rat hepatocytes. Toxicol. Sci. 69 (2002) 424-432
16. LeBel C.P., Ischiropoulos H., and Bondy S.C. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5 (1992) 227-231
17. Lu L.S., Wu C.C., Hung L.M., Chiang M.T., Lin C.T., Lin C.W., and Su M.J. Apocynin alleviated hepatic oxidative burden and reduced liver injury in hypercholesterolaemia. Liver Int. 27 (2007) 529-537
18. Luyendyk J.P., Shores K.C., Ganey P.E., and Roth R.A. Bacterial lipopolysaccharide exposure alters aflatoxin B(1) hepatotoxicity: benchmark dose analysis for markers of liver injury. Toxicol. Sci. 68 (2002) 220-225
19. MacRae W.D., and Stich H.F. Induction of sister-chromatid exchanges in Chinese hamster ovary cells by thiol and hydrazine compounds. Mutat. Res. 68 (1979) 351-365
20. Maru G.B., and Bhide S.V. Effect of antioxidants and antitoxicants of isoniazid on the formation of lung tumours in mice by isoniazid and hydrazine sulphate. Cancer Lett. 17 (1982) 75-80
21. Mitchell J.R., Long M.W., Thorgeirsson U.P., and Jollow D.J. Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy. Chest 68 (1975) 181-190
22. Mitchell J.R., Zimmerman H.J., Ishak K.G., Thorgeirsson U.P., Timbrell J.A., Snodgrass W.R., and Nelson S.D. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann. Intern. Med. 84 (1976) 181-192
23. Moldeus P., Hogberg J., and Orrenius S. Isolation and use of liver cells. Methods Enzymol. 52 (1978) 60-71
24. O'Brien P.J., Tafazoli S., Chan K., Mashregi M., Mehta R., and Shangari N. A hepatocyte inflammation model for carbonyl induced liver injury: drugs, diabetes, solvents, chlorination. In: Weiner H., Maser E., Lindahl R., and Plapp B. (Eds) (2007), Purdue University Press, West Lafayette, Indiana 105-112
25. Ortiz de Montellano P.R., and Kerr D.E. Inactivation of catalase by phenylhydrazine. Formation of a stable aryl-iron heme complex. J. Biol. Chem. 258 (1983) 10558-10563
26. 2 fluxes within cells. J. Biochem. Biophys. Methods 31 (1996) 59-67
27. Reinehr R., Becker S., Eberle A., Grether-Beck S., and Haussinger D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J. Biol. Chem. 280 (2005) 27179-27194
28. Roth R.A., Harkema J.R., Pestka J.P., and Ganey P.E. Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents?. Toxicol. Appl. Pharmacol. 147 (1997) 300-311
29. Rubin R.L. Drug-induced lupus. Toxicology 209 (2005) 135-147
30. Sarich T.C., Youssefi M., Zhou T., Adams S.P., Wall R.A., and Wright J.M. Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits. Arch. Toxicol. 70 (1996) 835-840
31. Sarich T.C., Adams S.P., Petricca G., and Wright J.M. Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor. J. Pharmacol. Exp. Ther. 289 (1999) 695-702
32. Scharer L., and Smith J.P. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. Ann. Intern. Med. 71 (1969) 1113-1120
33. Sendo T., Noda A., Noda H., Hsu K.Y., and Yamamoto Y. Metabolic hydrolysis of isoniazid by subcellular fractions of rat liver. J. UOEH. 6 (1984) 249-255
34. Starke P.E., Gilbertson J.D., and Farber J.L. Lysosomal origin of the ferric iron required for cell killing by hydrogen peroxide. Biochem. Biophys. Res. Commun. 133 (1985) 371-379
35. Tafazoli S., and O'Brien P.J. Peroxidases: a role in the metabolism and side effects of drugs. Drug Discov. Today 10 (2005) 617-625
36. Tafazoli S., Spehar D.D., and O'Brien P.J. Oxidative stress mediated idiosyncratic drug toxicity. Drug Metab Rev. 37 (2005) 311-325
37. Tafazoli S., Wright J.S., and O'Brien P.J. Prooxidant and antioxidant activity of vitamin E analogues and troglitazone. Chem. Res. Toxicol. 18 (2005) 1567-1574
38. Timbrell J.A., and Harland S.J. Identification and quantitation of hydrazine in the urine of patients treated with hydralazine. Clin. Pharmacol. Ther. 26 (1979) 81-88
39. Timbrell J.A., Scales M.D., and Streeter A.J. Studies on hydrazine hepatotoxicity. 2. Biochemical findings. J. Toxicol. Environ. Health 10 (1982) 955-968
40. Toth B., and Shubik P. Carcinogenesis in Swiss mice by isonicotinic acid hydrazide. Cancer Res. 26 (1966) 1473-1475
41. Tukov F.F., Maddox J.F., Amacher D.E., Bobrowski W.F., Roth R.A., and Ganey P.E. Modeling inflammation-drug interactions in vitro: a rat Kupffer cell-hepatocyte coculture system. Toxicol. In Vitro 20 (2006) 1488-1499
42. Uetrecht J. Current trends in drug-induced autoimmunity. Autoimmun. Rev. 4 (2005) 309-314
43. Whiting R.F., Wei L., and Stich H.G. Enhancement by transition metals of unscheduled DNA synthesis induced by isoniazid and related hydrazines in cultured normal and xeroderma pigmentosum human cells. Mutat. Res. 62 (1979) 505-515
44. Yard A.S., and McKennis Jr. H. Effect of structure on the ability of hydrazino compounds to produce fatty livers. J. Pharmacol. Exp. Ther. 114 (1955) 391-397
45. 2-mediated damage to lysosomal membranes of J-774 cells. Free Radic. Res. Commun. 18 (1993) 71-85
46. Zetterberg G., and Bostrom G. Mitotic gene conversion induced in yeast by isoniazid. Influence of a transition metal and of the physiological conditions of the cells. Mutat. Res. 91 (1981) 215-219
47. Zingale S.B., Minzer L., Rosenberg B., and Lee S.L. Drug induced lupus-like syndrome. Clinical and laboratory syndrome similar to systemic lupus erythematosus following antituberculous therapy: report of a case. Arch. Intern. Med. 112 (1963) 63-66